JEIL PHARMACEUTICAL CO., LTD.
🇰🇷South Korea
Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2019-11-18
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT03062397
- Locations
- 🇰🇷
Jeju National University Hospital, Jeju, Korea, Republic of
🇰🇷Ewha Womans University Seoul Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Guro Hospital, Seoul, Korea, Republic of
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-12-05
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT02982798
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-23
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 780
- Registration Number
- NCT02972268
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2018-07-06
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 237
- Registration Number
- NCT02827903
- Locations
- 🇰🇷
Youngnam University Hostpital, Daegu, Korea, Republic of
🇰🇷Myoung Ji Hospital, Gyeonggi-do, Korea, Republic of
🇰🇷Daeheon Eulji Medical Center, Daejeon, Korea, Republic of
The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT02494349
Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT02449187
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT02447367
Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-04-07
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 448
- Registration Number
- NCT02410083
The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers
- First Posted Date
- 2015-03-24
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02396069
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-Gu, Korea, Republic of
The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-03-13
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 41
- Registration Number
- NCT02387619
- Locations
- 🇰🇷
Yonsei University Health System, Seoul, Seodaemun-gu, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath